<div id="refs_global_1" class="showInBiblio">1.1.1   	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;1:1
</div>

<div id="refs_global_2" class="showInBiblio">1.1.2    	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;1:1-2
</div>

<div id="refs_global_1" class="showInBiblio">1.1.3/1 	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;1:8-9
</div>

<div id="refs_global_1" class="showInBiblio">1.1.3/2 	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;1:9,12-14;<br> 
	2. Rosenberg <i>et al. Nat Rev Immunol</i> 2013;13:9; <br>
	3. Chirumbolo S. Blood Transfus 2012;10:148
</div>

<div id="refs_global_1" class="showInBiblio">1.1.4	 	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;1:7-8
</div>

<div id="refs_global_1" class="showInBiblio">1.1.5		Pathology basis of disease. Normal Reference Range Table. 2004. http://web.squ.edu.om/med-lib/med_cd/e_cds/pathologic%20basis%20of%20disease/nrrt.htm. 		(accessed October 2013)
</div>

<div id="refs_global_1" class="showInBiblio">1.2.1/1 	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:26  
</div>

<div id="refs_global_1" class="showInBiblio">1.2.1/2 	
	<br>1. Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:17-27; 
	<br>2. Bianco P <i>et al. Stem Cells</i> 2001;19:180; 
	<br>3. Robb L. <i>Oncogene</i> 2007;26:6715; 
	<br>4. 		Kaushansky K. <i>Stem Cells</i> 1997;15(Suppl 1):97; 
	<br>5. Deutsch VR & Tomer A. <i>Br J Haematol</i> 2006;134:453; 
	<br>6. Zhang CC & Lodish HF. <i>Curr Opin Hematol</i> 			 2008;15:307
</div>

<div id="refs_global_1" class="showInBiblio">1.2.1.a<br>	
	1. Deutsch VR & Tomer A. <i>Br J Haematol</i> 2006;134:453; <br>
	2. Kaushansky K. <i>Stem Cells</i> 1997;15(Suppl 1):97; <br>
	3. Heckl D <i>et al. Blood</i> 2011;117:3737;<br>                     
	4. Savoia A <i>et al. Haematologica</i> 2007;92:1186; 5. Walne AJ <i>et al. Haematologica</i> 2012;97:524

</div>

<div id="refs_global_1" class="showInBiblio">1.2.1.b	Ninos JM <i>et al. J Transl Med</i> 2006;4:9
</div>

<div id="refs_global_1" class="showInBiblio">1.2.2		Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:26-27 


</div>

<div id="refs_global_1" class="showInBiblio">1.3.1		Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:18. Image adapted from Le T <i>et al</i>. First Aid for the USMLE Step 1: 20th Anniversary Edition. 			USA: The McGraw-Hill Companies, Inc. 123. 2010

</div>

<div id="refs_global_1" class="showInBiblio">1.3.2/1	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:27-28. Image adapted from Le T <i>et al</i>. First Aid for the USMLE Step 1: 20th Anniversary Edition. USA: 		                The McGraw-Hill Companies, Inc. 123. 2010

</div>

<div id="refs_global_1" class="showInBiblio">1.3.2a<br>	
	1. Tavian M & Péault B. <i>Int J Dev Biol</i> 2005;49:243;<br> 
	2. Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:19-20
</div>

<div id="refs_global_1" class="showInBiblio">1.3.2/2	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:29
</div>


<div id="refs_global_1" class="showInBiblio">1.3.2/3<br>	
	1. Deutsch VR & Tomer A. <i>Br J Haematol</i> 2006;134:453;<br> 
	2. Machlus KR & Italiano Jr. JE. <i>J Cell Biol</i>. 2013; 201:785;<br> 
	3. Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:29 
</div>


<div id="refs_global_1" class="showInBiblio">1.3.2/4	Pallister CJ & Watson MS. In <i>Haematology<i>. 2nd edn, 2011;2:34. Image adapted from Le Tao <i>et al</i>. First Aid for the USMLE Step 1: 20th Anniversary Edition. USA: The McGraw-Hill Companies, Inc. 123. 2010 

</div>


<div id="refs_global_1" class="showInBiblio">1.3.3		
	1. Zhang CC & Lodish HF. <i>Curr Opin Hematol</i> 2008;15:307;<br> 
	2. Metcalf D. Blood 2008;111:485 
</div>


<div id="refs_global_1" class="showInBiblio">1.3.3.a	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:23 
</div>


<div id="refs_global_1" class="showInBiblio">1.4.1/1	Bolon B. <i>Toxicol Pathol</i> 2012;40:216
</div>

<div id="refs_global_1" class="showInBiblio">1.4.1<br>	               
	1. Chemotaxis and adherence of microbe to phagocyte; <br>
	2. Ingestion of microbe;<br> 
	3. Phagosome formation; <br>
	4. Fusion of the phagosome with a lysosome to form a phagolysosome;<br> 
	5. Digestion of ingested microbe by enzymes;<br> 
	6. Formation of residual body containing indigestible material;<br> 
	7. Discharge of waste materials 
</div>

<div id="refs_global_1" class="showInBiblio">1.4.1/2	Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;2:30-35; 2. Janeway CA Jr <i>et al</i>. The Humoral Immune Response. In <i>Immunobiology: The Immune System in Health and Disease</i>. 5th edn. 2001. http://www.ncbi.nlm.nih.gov/books/NBK10752/ (accessed October 2013) 
</div>

<div id="refs_global_1" class="showInBiblio">1.4.1/3	Janeway CA Jr <i>et al</i>. T cell-mediated <i>immunity. In Immunobiology: The Immune System in Health and Disease</i>. 5th edn. 2001. http://www.ncbi.nlm.nih.gov/books/NBK10762/ (accessed October 2013); 2. Janeway CA Jr et al. T cell-mediated cytotoxicity. In <i>Immunobiology: The Immune System in Health and Disease</i>. 5th edn. 2001. http://www.ncbi.nlm.nih.gov/books/NBK27101/ (accessed October 2013)

</div>

<div id="refs_global_1" class="showInBiblio">1.4.1.a<br>	
	1. Zajac AJ & Harrington LE. In <i>Encyclopaedia of virology</i>. Third edition. 70. 2008; <br>
	2. Bolon B. <i>Toxicol Pathol</i> 2012;40:216

</div>


<div id="refs_global_1" class="showInBiblio">1.4.2<br>
	1. Bolon B. <i>Toxicol Pathol</i> 2012;40:216; <br>
	2. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647 
</div>


<div id="refs_global_1" class="showInBiblio">2.1.1/1<br>
	1. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43; <br>
	2. Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365;<br>
	3. Dokal I & Vulliamy T. <i>Blood Reviews</i> 2008; 22:141;<br>
	4. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221
</div>


<div id="refs_global_1" class="showInBiblio">2.1.1/2<br>
	1. Montané E <i>et al. Haematologica</i> 2008;93:518;<br>
	2. Hamerschlak N <i>et al. Sao Paulo Med</i> J 2005;123:101;<br> 
	3. Issaragrisil S <i>et al. Blood</i> 2006;107:1299;<br> 
	4. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162
</div>

<div id="refs_global_1" class="showInBiblio">2.2.1<br>
	Dokal I & Vulliamy T. <i>Blood Reviews</i> 2008;22:141
</div>

<div id="refs_global_1" class="showInBiblio">2.2.2/1<br>
	1. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162;<br>  
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>  
	3. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br> 
	4. Montané E <i>et al. Haematologica</i> 2008;93:518;<br>
	5. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br> 
	6. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647
</div>


<div id="refs_global_1" class="showInBiblio">2.2.2/2<br>
	1. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	2. Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011;2011:76
</div>


<div id="refs_global_1" class="showInBiblio">2.2.2.a<br>
	1. Alter BP. <i>Hematology Am Soc Hematol Educ Program</i> 2007:29;<br>
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	3. Dokal I & Vulliamy T. <i>Blood Reviews</i> 2008;22:141;<br>
	4. Davies JK & Guinan EC. <i>Br J Haematol</i> 2007;136:549;<br>
	5. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647
</div>


<div id="refs_global_1" class="showInBiblio">2.2.3<br>
	1. Alter BP. <i>Hematology Am Soc Hematol Educ Program</i> 2007:29;<br> 
	2. Davies JK & Guinan EC. <i>Br J Haematol</i> 2007;136:549;<br> 
	3. Emedical Blogspot. http://emedicalppt.blogspot.co.uk/2011/07/fanconi-anemia.html;<br>
	4. The Geneva Foundation for Medical Education and Research. http://www.gfmer.ch/genetic_diseases_v2/gendis_detail_list.php?cat3=107 (accessed October 2013);<br>
	5. Dokal I & Vulliamy T. <i>Blood Reviews</i> 2008;22:141
</div>

<div id="refs_global_1" class="showInBiblio">2.2.4/1<br>
	1. Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2006;72;<br>
	2. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	3. Lu J <i>et al. Blood</i> 2004;103:4588
</div>


<div id="refs_global_1" class="showInBiblio">2.2.4/2<br>
	1. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br> 
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	3. Pallister CJ & Watson MS. In <i>Haematology</i>. 2nd edn, 2011;3;<br>
	4. DrFO.Jr.Tn. Petechial rash. http://commons.wikimedia.org/wiki/File:Petechial_rash.JPG (accessed October 2013)
</div>


<div id="refs_global_1" class="showInBiblio">2.2.4a<br>
	1. Davies JK & Guinan EC. <i>Br J Haematol</i> 2007;136:549;<br> 
	2. Montané E <i>et al. Haematologica</i> 2008;93:518;<br>
	3. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br>
	4. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	5. Dokal I & Vulliamy T.  <i>Blood Reviews</i> 2008;22:141
</div>


<div id="refs_global_1" class="showInBiblio">2.2.4b<br>
	1. Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2006;72;<br> 
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	3. Oostercamp HM <i>et al. Br J Haematol</i> 1998;103:315;<br>
	4. Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365
</div>


<div id="refs_global_1" class="showInBiblio">2.3.1/1<br>
	Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365
</div>


<div id="refs_global_1" class="showInBiblio">2.3.1/2<br>
	1. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162;<br>
	2. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	3. Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2006;72;<br> 
	4. Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2/1<br>
	Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2013;76
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2.a<br>
	1. Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365;<br> 
	2. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647 
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2.b<br>
	Young NS & Maciejewski J. <i>N Eng J Med</i> 1997;336:1365 
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2/2<br>
	1. University of Minnesota Medical Centre, Fairview. http://www.uofmmedicalcenter.org/healthlibrary/Article/40317(accessed October 2013);
	2. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2/2<br>
	1. University of Minnesota Medical Centre, Fairview. http://www.uofmmedicalcenter.org/healthlibrary/Article/40317(accessed October 2013);
	2. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2/3<br>
	1. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br>
	2. Afable MG <i>et al. Hematology Am Soc Hematol Educ Program</i> 2011;90;<br>
	3. Maciejewski JP & Selleri C.<i>Leukaemia & Lymphoma</i> 2004:45:433  
</div>


<div id="refs_global_1" class="showInBiblio">2.3.2.c<br>
	1. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162;<br> 
	2. Afable MG <i>et al. Hematology Am Soc Hematol Educ Program</i> 2011;90;<br>
	3. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647  
</div>


<div id="refs_global_1" class="showInBiblio">2.4.1<br>
	1. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	2. Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011:76;<br>
	3. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	4. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185
</div>


<div id="refs_global_1" class="showInBiblio">2.4.2<br>
	Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43
</div>


<div id="refs_global_1" class="showInBiblio">2.4.3<br>
	1. Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011:76;<br>
	2. Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2006;72;<br>
	3. Steinberg MH. <i>Scientific World Journal</i> 2008;8:1295
</div>


<div id="refs_global_1" class="showInBiblio">2.4.3a<br>
	Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011;2011:76
</div>


<div id="refs_global_1" class="showInBiblio">2.4.3b<br>
	1. Steinberg MH. <i>Scientific World Journal</i> 2008;8:1295;<br>
	2. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185 
</div>


<div id="refs_global_1" class="showInBiblio">2.5.1<br>
	1. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	3. Dokal I & Vulliamy T. <i>Blood Reviews</i> 2008;22:141;<br>
	4. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br>
	5. Bacigalupo A & Passweg J <i>et al. Haematol Oncol Clin N Am</i> 2009;23:159;<br>
	6. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185
</div>

<div id="refs_global_1" class="showInBiblio">2.5.2<br>
	1. Scheinberg P. <i>Blood</i> 2012;120:1185; 
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43 
</div>


<div id="refs_global_1" class="showInBiblio">2.5.3<br>
	Scheinberg P. <i>Blood</i> 2012;120:1185
</div>


<div id="refs_global_1" class="showInBiblio">2.6.1<br>
	1. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;
	2. Bacigalupo A & Passweg J <i>et al. Haematol Oncol Clin N Am</i> 2009;23:159;
	3. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;
	4. Young NS <i>et al. Biol Blood Marrow</i> Transplant 2010;16:S119
</div>


<div id="refs_global_1" class="showInBiblio">2.6.1a<br>
	1. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br>
	2. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	3. Casadevall N <i>et al. N Eng J Med</i> 2002;346:469;<br>
	4. Young NS <i>et al. Biol Blood Marrow Transplant</i> 2010;16:S119;<br>
	5. Lee JW <i>et al. Blood</i> 2010;116:2448
</div>

<div id="refs_global_1" class="showInBiblio">2.6.2/1<br>
	1. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br>
	2. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br>
	3. Socie G <i>et al. N Eng J Med</i> 1993;329:1152;<br>
	4. Bacigalupo A & Passweg J <i>et al. Haematol Oncol Clin N Am</i> 2009;23:159;<br>
	5. Socie G. <i>Hematology Am Soc Hematol Educ Program</i> 2013;82;<br>
	6. Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011;2011:76<br>
	7. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2a<br>
	1. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br> 
	2. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br> 
	3. Medical necessity guidelines. Stem-cell transplantation 		for aplastic anaemia and Fanconi anaemia. 2013. http://www.cigna.com/sites/careallies/pdf/CA0293_sct_aplastic_anemia.pdf. (accessed November 2013)
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2.b<br>
	Young NS <i>et al. Blood</i> 2006;108:2509
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2c<br>
	1. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br>
	2. Viollier R <i>et al. Bone Marrow Transplant</i> 2008;41:45;<br>
	3. Kosaka Y <i>et al. Blood</i> 2008;111:1054;<br>
	4. Perez-	Albuerne ED <i>et al</i>. 2008;141:216;<br>
	5. Bacigalupo A <i>et al. Haematologica</i> 2010;95:976;<br>
	6. Kang HJ <i>et al. Biol Blood Marrow Transplant</i> 2010;16:1582;<br>
	7. Yagasaki H <i>et al. Bone Marrow Transplant</i> 2010;45:1508;<br>
	8. Lee JE <i>et al. Biol Blood Marrow Transplant</i> 2011;17:101;<br>
	9. Gupta V <i>et al. Haematologica</i> 2010;95:2119 
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2.d<br>
	Centre for International Blood and Marrow Transplant Research. 2012. http://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/Pages/index.aspx 			(accessed October 2013)
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2.e<br>
	1. Eapen M & Horowitz MM. <i>Hematology Am Soc Hematol Educ Program</i> 2010;2010:43; 2. MacMillan ML <i>et al. Semin Hematol</i> 2010;47:37
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2.f<br>
	1. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;
	2. Guinan EC. Hematology Am Soc Hematol Educ Program 2011;2011:76; 
	3. Young NS <i>et al. Biol Blood Bone Marrow Transplant</i> 2010;16:S119;
	4. Champlin RE <i>et al. Blood</i> 2007;109:4582;
	5. Maury S <i>et al. Haematologica</i> 2009;94:1312;
	6. Marsh JC <i>et al. Blood</i> 2011;118:2351 
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2/2<br>
	1. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br>
	2. Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011;2011:76;<br>
	3. Bacigalupo A & Passweg J. <i>Haematol Oncol Clin N Am</i> 2009;23:159;<br>
	4. Young NS <i>et al. Curr Opin Hematol</i>. 2008;15:162;<br>
	5. Scheinberg P. <i>Hematology Am Soc Hematol Educ Program</i> 2012;292;<br>
	6. Scheinberg P <i>et al. Br J Haematol</i> 2006;133:622;<br>
	7. Di Bona E <i>et al. Br J Haematol</i> 1999;107:330;<br>
	8. .Scheinberg P <i>et al. N Eng J Med</i> 2011;365:430; <br>
	9.  Young NS <i>et al. Blood</i> 2006;108:2509;<br>
	10. Scheinberg P <i>et al. Blood</i> 2012;120:1185;<br>
	11. Passweg J <i>et al. J Clin Oncol</i> 2011;29:303;<br>
	12. Matsuda S & Koyasu S. <i>Immunopharmacology</i> 2000;47:119;<br>
	13. Maciejewski JP & Selleri C. <i>Leukaemia & Lymphoma</i> 2004;45:433;<br>
	14. Afable MG <i>et al. Hematology Am Soc Hematol Educ Program</i> 2011;90
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2/3<br>
	1. Zheng Y <i>et al. Experiment Hematol</i> 2006;34:826;<br> 
	2. Atta EH <i>et al. Ann Hematol</i> 2010;89:851;<br>
	3. Afable MG <i>et al. Haematologica</i> 2011;96:1269;<br>
	4. Scheinberg P <i>et al. N Eng J Med</i> 2011;365:430;<br>
	5. NHS North East Treatment Advisory Group appraisal report. 2012. http://www.netag.nhs.uk/files/appraisal-reports/ATG%20for%20-adult-%20aplastic%20anaemia%20-%20NETAG%20appraisal%20report%20-%20Dec2012.pdf (accessed October 2013);<br>
	6. Risitano AM <i>et al. Br J Haematol</i> 2010;148:791
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2/4<br>
	1. Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2013;76;<br>
	2. Gurion R <i>et al. Haematologica</i> 2009;94:712
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2.g<br>
	1. Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011;2011:76;<br> 
	2. Kamio T <i>et al. Haematologica</i> 2011;96:814;<br>
	3. Scheinberg P <i>et al. Br J Haematol</i> 2006;133:606;<br>
	4. Scheinberg P <i>et al. Haematologica</i> 2009;94:348 
	5. Gurion R <i>et al. Haematologica</i> 2009;94:712;<br>
	6. Brodsky RA <i>et al. Blood</i> 2010;115:2136;<br>
	7. Risitano AM <i>et al. Br J Haematol</i> 2010;148:791;<br>
	8. Locasciulli A <i>et al. Haematologica</i> 2007;92:11;<br>
	9. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43
</div>



<div id="refs_global_1" class="showInBiblio">2.6.2/5<br>
	1. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br>
	2. Scheinberg P<i> et al. Br J Haematol</i> 2006;133:622;<br>
	3. Scheinberg P <i>et al. Hematology Am Soc Hematol Educ Program</i> 2012;292
</div>


<div id="refs_global_1" class="showInBiblio">2.6.2/6<br>
	1. Marsh JWC & Kulasekararaj AG. <i>Blood</i> 2013;122:3561;<br>
	2. Young NS <i>et al. Blood</i> 2006;108:2509;<br>
	3. Scheinberg P. <i>Hematology Am Soc Hematol Educ Program</i> 2012;292;<br>
	4. Valdez JM <i>et al. Clin Infect Dis</i> 2011;52:726;<br>
	5. Passweg JR <i>et al. Bone Marrow Transplant</i> 2006;37:641;<br>
	6. Perez-Albuerne ED <i>et al. Br J Haematol</i> 2008;141:216;<br>
	7. Liu H-L <i>et al. Bone Marrow Transplant</i> 2012;47:1186;<br>
	8. Scheinberg P <i>et al. Br J Haematol</i> 2006;133:622;<br>
	9. Di Bona E <i>et al. Br J Haematol</i> 199;107:330;<br>
	10. Scheinberg P <i>et al. Blood</i> 2012;119:345;<br>
	11. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	12. Gupta V <i>et al. Haematologica</i> 2010;95:2119;<br>
	13. Locasciulli A <i>et al. Haematologica</i> 2007;92:11;<br>
	14. Valdez JM <i>et al. Clin Infect Dis</i> 2011;52:726
</div>

<div id="refs_global_1" class="showInBiblio">2.6.2/7<br>
	1. Scheinberg P <i>et al. Blood</i> 2012;120:1185;<br>
	2. Lee JW <i>et al. Blood</i> 2010;116:2448;<br>
	3. Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43;<br>
	4. Gurion R <i>et al. Haematologica</i> 2009;94:712;<br>
	5. De Zern A & Brodsky RA. <i>Expert Rev Hematol</i> 2011;4:221;<br>
	6. Dutch Blood Transfusion Guideline. 2011. http://www.sanquin.nl/repository/documenten/en/prod-en-dienst/287294/blood-transfusion-guideline.pdf (accessed January 2014);<br>
	7. Annual SHOT report. Serious Hazards of Transfusion steering group. 2011. http://www.shotuk.org/wp-content/uploads/2012/07/SHOT-ANNUAL-REPORT_FinalWebVersionBookmarked_2012_06_22.pdf (accessed January 2014);<br>
	8. Gilstad CW. <i>Curr Opin Hematol</i> 2003;10:419 
</div>

<div id="refs_global_1" class="showInBiblio">2.6.3<br>
	1. Olnes MJ <i>et al. N Eng J Med</i> 2012;367:11;<br>
	2. Marsh JWC & Kulasekararaj AG. <i>Blood</i> 2013;122:3561;<br>
	3. Scheinberg P <i>et al. Blood</i> 2012;119:345;<br>
	4. Sloand EM <i>et al. Haematologica</i> 2010;95:382
</div>


<div id="refs_global_1" class="showInBiblio">2.6.3.a<br>
	1. Aplastic Anaemia Therapeutics – Pipeline Assessment and Market Forecasts to 2019.” Research and Markets, February 2012. http://www.researchandmarkets.com/reports/2114301/aplastic_anemia_therapeutics_pipeline.htm (accessed Oct 2013);<br>
	2. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	3. Di Bona E <i>et al. Br J Haematol</i> 1999;107:330;<br>
	4. Scheinberg P <i>et al. Br J Haematol</i> 2006;133:622;<br>
	5. Lee JW <i>et al. Blood</i> 2010;116:2448;<br>
	6. Dutch Blood Transfusion Guideline. 2011. http://www.sanquin.nl/repository/documenten/en/prod-en-dienst/287294/blood-transfusion-guideline.pdf (accessed January 2014);<br>
	7. Scheinberg P <i>et al. Blood</i> 2012;120:1185;<br>
	8. Maciejewski JP & Selleri C. <i>Leukaemia & Lymphoma</i> 2004;45:433
</div>


<div id="refs_global_1" class="showInBiblio">2.6.3.b<br>
	1. Scheinberg P. <i>Hematology Am Soc Hematol Educ Program</i> 2012;292;<br>
	2. Passweg JR <i>et al. Bone Marrow Transplant</i> 2006;37:641;<br>
	3. Perez-Albuerne <i>et al. Br J Haematol</i> 2008;141:216;<br>
	4. Liu H-L <i>et al. Bone Marrow Transplantation</i> 2012;47:1186;<br>
	5. Peffault de Latour R <i>et al. Biol Blood Marrow Transplant</i> 2011;17:78;<br>
	6. Koh KN <i>et al. Br J Haematol</i> 2012;157:125;<br>
	7. De Zern AE <i>et al. Bone Marrow Transplant</i> 2011;46:1012;<br>
	8. Kwon M <i>et al. Biol Blood Marrow Transplant</i> 2013;19:143
</div>


<div id="refs_global_1" class="showInBiblio">2.6.3.d<br>
	1. Scheinberg P. <i>Hematology Am Soc Hematol Educ Program</i> 2012;2012:292;<br>
	2. Scheinberg P <i>et al. Blood</i> 2012;119:345;<br>
	3. Risitano AM <i>et al. Br J Haematol</i> 2010;148:791;<br>
	4. Kim H <i>et al. Leuk Res</i> 2009;33:222;<br>
	5. Valdez JM <i>et al. Clin Infect Dis</i> 2011;52:726
</div>


<div id="refs_global_1" class="showInBiblio">2.6.4<br>
	1. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221;<br>
	2. Bacigalupo A & Passweg J <i>et al. Haematol Oncol Clin N Am</i> 2009;23:159;<br>
	3. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br>
	4. Young NS <i>et al. Biol Blood Marrow Transplant</i> 2010;16:S119;<br>
	5. Lee JW <i>et al. Blood</i> 2010;116:2448;<br>
	6. Young NS <i>et al. Blood</i> 2006;108:2509
</div>


<div id="refs_global_1" class="showInBiblio">2.7.1<br>
	1. Gupta V <i>et al. Haematologica</i> 2010;95:2119;<br>
	2. Peinemann F <i>et al. Haematologica</i> 2009;94:1732;<br>
	3. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185;<br>
	4. Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647;<br>
	5. Valdez JM <i>et al. Clin Infect Dis</i> 2011;52:726
</div>


<div id="refs_global_1" class="showInBiblio">2.7.2<br>
	Locasciulli A <i>et al. Haematologica</i> 2007;92:11 
</div>


<div id="refs_global_1" class="showInBiblio">2.7.3<br>
	Gupta V <i>et al. Haematologica</i> 2010;95:2119
</div>

<div id="refs_global_1" class="showInBiblio">2.8.1/1<br>
	1. European Group for Blood and Marrow Transplantation. The complete treatment algorithm for SAA. 2010. http://www.ebmt.org/Contents/Resources/Library/Slidebank/EBMT2010SlideBank/Documents/EBMT%202010%20Session%20slides/SAA_complete_treat_algorithm_v1.pdf (accessed December 2013)
</div>


<div id="refs_global_1" class="showInBiblio">2.8.1.a<br>
	Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43
</div>


<div id="refs_global_1" class="showInBiblio">2.8.1/2<br>
	Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185
</div>


<div id="refs_global_1" class="showInBiblio">2.8.1b<br>
	Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185
</div>


<div id="refs_global_1" class="showInBiblio">2.8.2/1<br>
	Marsh JCW & Kulasekaraj AG. <i>Blood</i> 2013;122:3561
</div>


<div id="refs_global_1" class="showInBiblio">2.8.2/2<br>
	Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185
</div>


<div id="refs_global_1" class="showInBiblio">2.9.1<br>
	Viollier R <i>et al. Ann Haematol</i> 2005;84:47
</div>


<div id="refs_global_1" class="showInBiblio"> <b>Chemical structure of eltrombopag</b> <br>
	1. Erickson-Miller C <i>et al. Exp Hematol</i> 2005;33:85<br>
	2. Bussel JB & Pinheiro MP. In <i>Hematopoietic Growth Factors in Oncology</i>. 2011<br>
	3. Kuter DJ <i>et al. Semin Hematol</i> 2010;47:243<br>
	4. GlaxoSmithKline. Promacta (eltrombopag). Prescribing Information (draft). 2014<br>
	5. Roth M <i>et al. Blood</i> 2012;120:386 (supplemental material)<br>
	6. GlaxoSmithKline. Eltrombopag tablets for oral use. Prescribing Information (draft). 2014
</div>

<div id="refs_global_1" class="showInBiblio"> <b>Eltrombopag interacts with the thrombopoietin receptor</b><br>
	1. Erickson-Miller C <i>et al. Exp Hematol</i> 2005;33:85<br>
	2. Bussel JB & Pinheiro MP. In <i>Hematopoietic Growth Factors in Oncology</i>. 2011<br>
	3. Kuter DJ <i>et al. Seminars Hematol</i> 2010;47:243<br>
	4. Kuter DJ. <i>Blood</i> 2007;109:4607<br>
	5. Cook L <i>et al. Drug Des Devel Ther</i> 2010;4:139<br>
	6. Stasi R <i>et al. Expert Opin Drug Discov</i> 2009;4:85<br>
	7. Sun H <i>et al. Stem Cell Res</i> 2012;9:77<br>
	8. Psaila B <i>et al. Blood</i> 2012;119:4066<br>
	9. Jenkins JM <i>et al. Blood</i> 2007;109:4739<br>
	10. Zeigler FC <i>et al. Blood </i>1994;84:4045<br>
	11. Alexander WS <i>et al. Blood</i> 1996;87:2162<br>
	12. Kimura S <i>et al. Proc Natl Acad Sci USA</i> 1998;95:1195<br>
	13. Qian H <i>et al. Cell Stem Cell</i> 2007;1:671<br>
	14. Geddis AE. <i>Pediatr Blood Cancer</i> 2011;57:199
</div>

<div id="refs_global_1" class="showInBiblio"> <b>Role of thrombopoietin in haematopoiesis</b><br>
	1. Kaushansky K. <i>Stem Cells</i> 1997;15:97<br>
	2. Jacobsen SE <i>et al. Stem Cells</i> 1996;14(Suppl 1);173<br>
	3. Robb L <i>et al. Cytokine</i> 2007;26:6715<br>
	4. Reya T. <i>Recent Prog Horm Res</i> 2003;58:283<br>
	5. Townsley DM <i>et al. Int J Hematol</i> 2013;98:48<br>
	6. Zeigler FC <i>et al. Blood</i> 1994;84:4045<br>
	7. Kimura S <i>et al. Proc Natl Acad Sci</i> USA 1998;95:1195<br>
	8. Qian H <i>et al. Cell Stem Cell</i> 2007;1:671
</div>

<div id="refs_global_1" class="showInBiblio"> <b>Role of thrombopoietin in aplastic anaemia</b><br>
	1. Townsley DM <i>et al. Int J Hematol</i> 2013;98:48<br>
	2. Geddis AE. <i>Pediatr Blood Cancer</i> 2011;75:199<br>
	3. Marsh JCW <i>et al. Br J Haematol</i> 1996;95:605<br>
	4. Emmons RV <i>et al. Blood</i> 1996;87:4068<br>
	5. Zeigler FC <i>et al. Blood</i> 1994;85:4045<br>
	6. Kimura S <i>et al. Proc Natl Acad Sci USA</i> 1998;95:1195<br>
	7. Alexander WS <i>et al. Stem Cell</i> 1996;14(Suppl 1):124<br>
	8. Qian H <i>et al. Cell Stem Cell</i> 2007;1:671<br>
	9. Kuter DJ <i>et al. Blood</i> 1995;85:2720
</div>


<div id="refs_global_1" class="showInBiblio"> <b>Rationale for eltrombopag use in aplastic anaemia</b><br>
	GSK. Revolade (eltrombopag). Summary of Product Characteristics. 2012<br>
	GSK. Promacta (eltrombopag). Prescribing Information (draft). 2014<br>
	Olnes M <i>et al. N Engl J Med</i> 2012;367:11<br>
	Erickson-Miller C <i>et al. Stem Cells</i> 2009;27:424<br>
	Young NS. <i>Hematology Am Soc Hematol Educ Program</i> 2013;76<br>
	Gurion R <i>et al. Haematologica</i> 2009;94:712<br>
	Mavroudi I <i>et al. Leuk Res</i> 2011;35:323<br>
	Feng X <i>et al. Haematologica</i> 2011;96:602<br>
	Sun H <i>et al. Stem Cell Res</i> 2012;9:77
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>Effect of eltrombopag on expansion of haematopoietic<br> stem/progenitor cells and multilineage haematopoiesis</b><br>
	Sun H <i>et al. Stem Cell Res</i> 2012;9:77
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>Potential outcomes of stem cell stimulation by eltrombopag</b><br> 
	Adapted from Marsh JCW & Mufti GJ. <b>Blood</b> 2014;123:1774
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Phase II study in refractory aplastic anaemia: study design and inclusion criteria</b><br> 
	1. Olnes M <i>et al. N Engl J Med</i> 2012;367:11<br>
	2. GlaxoSmithKline. Data on File. Study protocol #09-H-0154. 2014<br>
	3. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014<br>
	4. ClinicalTrials.gov. NCT00922883. http://clinicaltrials.gov/show/NCT00922883. Updated January 2014 (accessed February 2014)<br>
	5. Cheng G <i>et al. Lancet</i> 2011;377:393;<br>
	6. Afdhal NH <i>et al. Gastroenterology</i> 2014;146:442
</div>


<div id="refs_global_1" class="showInBiblio">
    <b>Phase II study in refractory aplastic anaemia: key endpoints</b><br> 
	Olnes M <i>et al. N Engl J Med</i> 2012;367:11
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>Phase II study in refractory aplastic anaemia: data analysis</b><br> 
	1. Olnes M <i>et al. N Engl J Med</i> 2012;367:11<br>
	2. Desmond R <i>et al. Blood</i> 2014;123:1818
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Phase II study in refractory aplastic anaemia: baseline characteristics (cohorts 1 and 2)</b><br> 
	1. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014<br>
	2. GlaxoSmithKline. Eltrombopag tablets for oral use. Prescribing Information (draft). 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>   Phase II study in refractory aplastic anaemia: improved haematological parameters with eltrombopag  </b><br> 
	1. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014<br>
	2. Olnes M <i>et al. N Engl J Med</i> 2012;367:11
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>Phase II study: eltrombopag can produce a multilineage response over time in refractory aplastic anaemia </b><br> 
	GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>Phase II study in refractory aplastic anaemia: normalisation of bone marrow cellularity </b><br> 
	1. Adapted from Olnes M <i>et al. N Engl J Med</i> 2012;367:11<br>
	2. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Phase II study in refractory aplastic anaemia: longer duration of transfusion independence </b><br> 
	GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Platelet and red blood cell transfusion independence </b><br> 
	1. Adapted from Olnes M <i>et al. N Engl J Med</i> 2012;367:11<br>
	2. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Phase II study in refractory aplastic anaemia: maintained response after eltrombopag discontinuation</b><br> 
	1. GlaxoSmithKline. Data on File. Clinical study report #ELT112523; 2014<br>
	2. Desmond R <i>et al. Blood</i> 2014;123:1818
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Phase II study in refractory aplastic anaemia: eltrombopag treatment is generally well tolerated </b><br> 
	GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b>Phase II study in refractory aplastic anaemia: maintained response after eltrombopag discontinuation</b><br> 
	1. Valdez JM <i>et al. Clin Infect Dis</i> 2011;52:726<br> 
	2. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
</div>

<div id="refs_global_1" class="showInBiblio">
    <b> Risk of cytogenetic abnormalities and progression to clonal disorders </b><br> 
	1. Townsley DM <i>et al. Int J Hematol</i> 2013;98:48
	2. Afable MG <i>et al. Hematology Am Soc Hematol Educ Program</i> 2011;90
	3. GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014
	4. Desmond R <i>et al. Blood</i> 2014;123:1818
	5. Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162
	6. Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185
	7. DeZern AE & Brodsky RA. <i>Exp Rev Hematol</i> 2011;4:221
	8. GlaxoSmithKline. Data on File. Clinical overview module 2.5. 2014
</div>




    <!-- DO NOT modify the below div, it's used at runtime -->
    <div id="refsContainer"></div>
